TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00683267

Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“Enrollment of patients has halted prematurely and will not resume. No future patients will be enrolled or treated.”

The sponsor’s own words in the registry.

Life of this trial

200720082009Started2007-09Registered2008-05-21Primary completion2008-11Stopped2008-12

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Anesiva, Inc.
Sponsor type
Industry
Conditions
Arthroplasty
Interventions
4975, highly purified capsaicin; Placebo
Participants
118
Sites
10
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.